scholarly journals Perceptions of interprofessional collaboration of general practitioners and community pharmacists - a qualitative study

2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Christin Löffler ◽  
Carolin Koudmani ◽  
Femke Böhmer ◽  
Susanne D. Paschka ◽  
Jennifer Höck ◽  
...  
Keyword(s):  
Qualitative Study ◽  
General Practitioners ◽  
Interprofessional Collaboration ◽  
Community Pharmacists

scholarly journals Positioning Each Other: A Metasynthesis of Pharmacist-Physician Collaboration

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Hilde Rakvaag ◽  
Gunn Elisabeth Søreide ◽  
Reidun Lisbet Skeide Kjome
Keyword(s):  
Health Care ◽  
General Practitioners ◽  
Patient Outcomes ◽  
Interprofessional Collaboration ◽  
Community Pharmacists ◽  
Proactive Approach ◽  
Ethnographic Approach ◽  
Successful Collaboration ◽  
Taking Responsibility

Abstract Interprofessional collaboration between different professions within health care is essential to optimize patient outcomes. Community-pharmacists (CPs) and general-practitioners (GPs) are two professions who are encouraged to increase their collaboration. In this metasynthesis we use a meta-ethnographic approach to examine the interpersonal aspects of this collaboration, as perceived by the professionals themselves. The metasynthesis firstly suggests that CPs and GPs have differing storylines about the cooperation between them. Secondly, CPs seem to position their profession in relation to the GPs, whereas GPs do not rely on the CPs to define their professional position. A successful collaboration between the two professions requires the CPs to reposition themselves through adopting a proactive approach towards the GPs. This proactive approach should comprise the delivery of specific clinical advice, as well as taking responsibility for this advice. In this way, they can build a more coinciding storyline of the joint agenda of improved patientcare.

scholarly journals Complementing or conflicting? How pharmacists and physicians position the community pharmacist

2020 ◽  
Vol 18 (3) ◽  
pp. 2078
Author(s):  
Hilde Rakvaag ◽  
Gunn E. Søreide ◽  
Eivind Meland ◽  
Reidun L. Kjome
Keyword(s):  
Focus Group ◽  
General Practitioners ◽  
Interprofessional Collaboration ◽  
Community Pharmacists ◽  
Active Role ◽  
Structured Interview ◽  
Study Data ◽  
Positioning Theory ◽  
Focus Group Interviews ◽  
Group Interviews

Background: Interprofessional collaboration between pharmacists and physicians in primary care has been linked to improved patient outcomes. How professionals position themselves and each other can shed light upon their relationship, and positioning theory can be used as a tool to better understand intergroup relations. Objectives: 1) To identify how community pharmacists position themselves, and how they are positioned by general practitioners. 2) To assess how well these positions correspond, how the positions align with a proactive position for the pharmacists, and discuss how the positions could potentially impact collaboration. Methods: In this qualitative study, data were collected through six focus group interviews held between June and October 2019, three with pharmacists and three with physicians. The focus group interviews were conducted using a semi-structured interview guide. Data were audio recorded, transcribed verbatim, and analyzed using the Systematic text condensation method. Positioning theory was used as a theoretical framework to identify the positions assigned to community pharmacists by the pharmacists themselves and by the physicians. Results: Twelve pharmacists and ten physicians participated. The pharmacists positioned themselves as the “last line of defense”, “bridge-builders”, “outsiders” – with responsibility, but with a lack of information and authority – and “practical problem solvers”. The physicians positioned pharmacists as “a useful checkpoint”, “non-clinicians” and “unknown”. Conclusions: The study revealed both commonalities and disagreements in how community pharmacists position themselves and are positioned by general practitioners. Few of the positions assigned to pharmacists by the physicians support an active role for the pharmacists, while the pharmacists´ positioning of themselves is more diverse. The physicians´ positioning of pharmacists as an unknown group represents a major challenge for collaboration. Increasing the two professions´ knowledge of each other may help produce new positions that are more coordinated, and thus more supportive towards collaboration.

scholarly journals Qualitative Study of Community Pharmacists’ and General Practitioners’ Views toward Pharmacovigilance in Lithuania

Healthcare ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 1072
Author(s):  
Agne Valinciute-Jankauskiene ◽  
Loreta Kubiliene
Keyword(s):  
Qualitative Study ◽  
General Practitioners ◽  
Patient Outcomes ◽  
Medication Management ◽  
Community Pharmacists ◽  
Basic Knowledge ◽  
Pharmacovigilance System ◽  
Face To Face ◽  
Study Approach ◽  
Baltic Countries

Lithuania is the leader in pharmacovigilance among the three Baltic countries. However, comparisons with other European countries are difficult because the reported number of adverse drug reactions (ADRs) in Lithuania is too low to rely on in terms of the annual use of medicines by the population over the year. The aim of this study was to explore challenges related to the understanding and practices of general practitioners and community pharmacists in reporting ADRs in Lithuania. The qualitative study approach of face-to-face interviews was used. All interviews were recorded, transcribed verbatim, and thematically analyzed. Twelve interviews with general practitioners and community pharmacists were conducted from March 2020 through December 2020. All participants had a basic knowledge of pharmacovigilance, but only four participants reported ADRs to the interviewer. Six main barriers regarding ADR reporting were identified, and appropriate interventions were suggested. The importance of collaboration between physicians and pharmacists was highlighted, and the need for guidelines supporting collaboration was expressed. Medications are becoming more complex, and comprehensive medication management is key for the optimization of patient outcomes. Our results reveal the need to improve and innovate the current pharmacovigilance system at all levels, starting from education for pharmacy and healthcare students and continuing through the development of ADR procedures.

scholarly journals Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Navina Gerlach ◽  
Matthias Michiels-Corsten ◽  
Annika Viniol ◽  
Tanja Schleef ◽  
Ulrike Junius-Walker ◽  
...  
Keyword(s):  
Qualitative Study ◽  
General Practitioners ◽  
Community Pharmacists ◽  
Professional Roles

Perceptions of collaboration between general practitioners and community pharmacists: findings from a qualitative study based in Spain

2014 ◽  
Vol 28 (4) ◽  
pp. 352-357 ◽  
Author(s):  
Anna Maria Jové ◽  
Ana Fernández ◽  
Carmel Hughes ◽  
Mireia Guillén-Solà ◽  
Marta Rovira ◽  
...  
Keyword(s):  
Qualitative Study ◽  
General Practitioners ◽  
Community Pharmacists

scholarly journals Professional Roles of General Practitioners, Community Pharmacists and Specialist Providers in Collaborative Medication Deprescribing - A Qualitative Study

2020 ◽  
Author(s):  
Navina Gerlach ◽  
Matthias Michiels-Corsten ◽  
Annika Viniol ◽  
Tanja Schleef ◽  
Ulrike Junius-Walker ◽  
...  
Keyword(s):  
Qualitative Study ◽  
General Practitioners ◽  
Collaborative Care ◽  
Social Influences ◽  
Theoretical Domains Framework ◽  
Community Pharmacists ◽  
Environmental Context ◽  
Structural Factors ◽  
Role Perceptions ◽  
Medication Optimization

Abstract Background: Collaborative care approaches between general practitioners (GPs) and pharmacists have received international recognition for medication optimization and deprescribing efforts. Although specialist providers have been shown to influence deprescribing, their profession so far remains omitted from collaborative care approaches for medication optimization. Similarly, while explorative studies on role perception and collaboration between GPs and pharmacists grow, interaction with specialists for medication optimization is neglected. Our qualitative study therefore aims to explore GPs’, community pharmacists’ and specialist providers’ role perceptions of deprescribing, and to identify interpersonal as well as structural factors that may influence collaborative medication optimization approaches.Method: Seven focus-group discussions with GPs, community pharmacists and community specialists were conducted in Hesse and Lower Saxony, Germany. The topic guide focused on views and experiences with deprescribing with special attention to inter-professional collaboration. We conducted conventional content analysis and conceptualized emerging themes using the Theoretical Domains Framework.Results: 26 GPs, four community pharmacists and three community specialists took part in the study. The main themes corresponded to the four domains ´Social/professional role and identity` (1), ´Social influences’ (2), ´Reinforcement` (3) and ´Environmental context and resources’ (4) which were further described by beliefs statements, that is inductively developed key messages. For (1), GPs emerged as central medication managers while pharmacists and specialists were assigned confined or subordinated tasks in deprescribing. Social influences (2) encompassed patients’ trust in GPs as a support, while specialists and pharmacists were believed to threaten GPs’ role and deprescribing attempts. Reinforcements (3) negatively affected GPs’ and pharmacists’ effort in medication optimization by social reprimand and lacking reward. Environmental context (4) impeded deprescribing efforts by deficient reimbursement and resources as well as fragmentation of care, while informational and gate-keeping resources remained underutilized. Conclusion: Understanding stakeholders’ role perceptions on collaborative deprescribing is a prerequisite for joint approaches to medication management. We found that clear definition and dissemination of roles and responsibilities are premise for avoiding intergroup conflicts. Role performance and collaboration must further be supported by structural factors like adequate reimbursement, resources and a transparent continuity of care.

scholarly journals Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate

2021 ◽  
Vol 12 ◽  
Author(s):  
Hernán Ramos ◽  
Juan Pardo ◽  
Rafael Sánchez ◽  
Esteve Puchades ◽  
Jordi Pérez-Tur ◽  
...  
Keyword(s):  
Primary Care ◽  
Cognitive Impairment ◽  
Early Detection ◽  
Clinical Diagnosis ◽  
General Practitioners ◽  
Interprofessional Collaboration ◽  
Community Pharmacists ◽  
Cognitive Test ◽  
Community Pharmacies

The increased pressure on primary care makes it important for other health care providers, such as community pharmacists, to collaborate with general practitioners in activities related to chronic disease care. Therefore, the objective of the present project was to develop a protocol of action that allows close pharmacist-physician collaboration to carry out a coordinated action for very early detection of cognitive impairment (CI).Methods: A comparative study to promote early detection of CI was conducted in 19 community pharmacies divided into two groups: one group with interprofessional collaboration (IPC) and one group without interprofessional collaboration (NonIPC). IPC was defined as an interactive procedure involving all pharmacists, general practitioners and neurologists. A total of 281 subjects with subjective memory complaints were recruited. Three tests were used in the community pharmacies to detect possible CI: Memory Impairment Screening, Short Portable Mental State Questionnaire, and Semantic Verbal Fluency. Individuals with at least one positive cognitive test compatible with CI, were referred to primary care, and when appropriate, to the neurology service. Finally, we evaluated the differences in clinical and diagnostic follow-up in both groups after six months.Results: The NonIPC study group included 38 subjects compatible with CI referred to primary care (27.54%). Ten were further referred to a neurology department (7.25%) and four of them (2.90%) obtained a confirmed clinical diagnosis of CI. In contrast, in the IPC group, 46 subjects (32.17%) showed results compatible with CI and were referred to primary care. Of these, 21 (14.68%) were subsequently referred to a neurology service, while the remaining 25 were followed up by primary care. Nineteen individuals out of those referred to a neurology service obtained a confirmed clinical diagnosis of CI (13.29%). The percentage of subjects in the NonIPC group referred to neurology and the percentage of subjects diagnosed with CI, was significantly lower in comparison to the IPC group (p-value = 0.0233; p-value = 0.0007, respectively).Conclusions: The creation of IPC teams involving community pharmacists, general practitioners, and neurologists allow for increased detection of patients with CI or undiagnosed dementia and facilitates their clinical follow-up. This opens the possibility of diagnosis in patients in the very early stages of dementia, which can have positive implications to improve the prognosis and delay the evolution of the disease.

Sign in / Sign up

Export Citation Format

Share Document